CSHL 2022 Microbiome Conference

微生物组会议 2022年10月25日至29日 冷泉港第三届国际微生物组大会 实验室将包括探索病因和治疗的最新研究，范围广泛 微生物相关疾病，整合了临床研究、微生物学、 免疫学、生态学、生物信息学和基因组学。从2019年的前两次会议(在- 人)和2020年(由于COVID而虚拟)，显然CSHL微生物组会议提供了 一个独特的论坛，各种各样的学科聚集在一起，催化新的想法和 综合办法侧重于微生物群在人类健康中发挥的各种作用。这个 本次会议所针对的微生物的明确宽泛定义将允许继续 由活跃在临床上的研究人员开发的思想、技术和理论的相互交融， 生态和进化研究路线。以及将老牌领导者带到 主讲人，本次会议将重点关注青年调查人员和实习生，促进科学研究 发展这一领域和开发新的临床和实验所需的相互作用 方法、诊断和治疗。这次会议将深入讨论这两个问题 用于阐明机制的实验和计算方法 微生物群落组装、炎症性、免疫性和传染性疾病。我们会 也探索微生物组在药物反应中的新角色。微生物组研究是 在口头陈述中的特色将包括细菌、真菌和病毒相关疾病，以及 包括微生物-微生物相互作用。口头和海报会议将集中讨论以下主要主题 微生物组和寄主反应，包括；微生物组的生态学；进化和 微生物组；健康；营养；环境与微生物组；动物模型；还原论者 模型；和技术。会议将包括两位全体主旨演讲者，他们将应邀发表 更长时间的谈话。口头会议将以两次受邀的演讲开始，这些演讲来自 菲尔德，然后是从提交的摘要中选择的6个较短的演讲。海报的收录 会议以及在每次演讲后分配充足的提问时间将鼓励 与会者进行了广泛的讨论。会议将足够小(250-350人 科学家亲自出席，增加虚拟观众以拓宽访问范围)，以促进 这些互动，但大到足以让更年轻的调查人员口头陈述 以及那些观点新颖的人。微生物组的多个方面的整合 研究将形成新的跨学科互动，推动这一创新 平移场。这次会议将为年轻的调查人员提供独特的机会 介绍他们的工作以及计算、实验和临床学科的结合。

MICROBIOME Conference October 25 – 29, 2022 The third installment of the international Microbiome conference at Cold Spring Harbor Laboratory will include the latest research exploring the etiology and treatment of a wide-range of microbe-associated diseases, integrating the disciplines of clinical research, microbiology, immunology, ecology, bioinformatics and genomics. From the prior two meetings in 2019 (in- person) and 2020 (virtual due to COVID), it was clear that the CSHL Microbiome meeting offers a unique forum where a wide variety of disciplines come together to catalyze new ideas and integrate approaches focused on the varied roles microbiomes play in human health. The explicitly broad definition of microbiomes targeted by this conference will allow for continued mutual fertilization of ideas, techniques and theories developed by researchers active in clinical, ecological and evolutionary lines of research. As well as bringing established leaders as speakers, this meeting will focus on young investigators and trainees to facilitate the scientific interactions necessary to grow this field and develop novel clinical and experimental approaches, diagnostics and therapies. The meeting will provide an in-depth focus on both experimental and computational approaches that are being used to elucidate the mechanisms of microbial community assembly, inflammatory, immunologic and infectious diseases. We will also explore novel roles for the microbiome in drug response. Microbiome studies that are featured in the oral presentations will include bacterial, fungal and viral associated disease, and include microbe-microbe interactions. Oral and poster sessions will focus on major themes of microbiome and the host response, including; Ecology of the Microbiome; Evolution and the Microbiome; Health; Nutrition; Environment and the Microbiome; Animal Models; Reductionist Models; & Technology. The meeting will include two plenary keynote speakers invited to give longer talks. The oral sessions will begin with two invited talks from established leaders in the field, followed by 6 shorter talks chosen from submitted abstracts. The inclusion of poster sessions as well as the allotment of ample time for questions following each talk will encourage extensive discussion between the participants. The meeting will be small enough (250 - 350 scientists attending in-person, with an additional virtual audience to broaden access) to facilitate these interactions, yet large enough to allow for oral presentations from younger investigators and those with novel perspectives. The integration of a wide variety of aspects of microbiome research will nucleate new interdisciplinary interactions that will drive this innovative translational field. This meeting will be distinct in the opportunities for young investigators to present their work and the coalescence of computational, experimental and clinical disciplines.